Evidence map›Paper›PMID 38356008›Full record

ArticleAnnals of nuclear medicine2024

Methyl-

Hikaru Niitsu, Nobuyoshi Fukumitsu, Keiichi Tanaka, Masashi Mizumoto, Kei Nakai, Masahide Matsuda, Eiichi Ishikawa, Kentaro Hatano, Tsuyoshi Hashimoto, Satoshi Kamizawa and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Comparison of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Potential impact of [Radiation oncology (London, England) · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hikaru NiitsuDepartment of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan. niitsu@pmrc.tsukuba.ac.jp.ORCID http://orcid.org/0000-0001-8127-254X
Nobuyoshi FukumitsuDepartment of Radiation Oncology, Kobe Proton Center, 1-6-8, Minatoshima-Minamimachi, Kobe, 650-0047, Japan.
Keiichi TanakaDepartment of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Masashi MizumotoDepartment of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Kei NakaiDepartment of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Masahide MatsudaDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Eiichi IshikawaDepartment of Neurosurgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Kentaro HatanoDepartment of Applied Molecular Imaging, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Tsuyoshi HashimotoDepartment of Radiology, AIC Imaging Center, 2-1-16 Amakubo, Tsukuba, Ibaraki, 305-0005, Japan.
Satoshi KamizawaDepartment of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Hideyuki SakuraiDepartment of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
University of Tsukuba · JPUniversity of Tsukuba Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate differences in uptake regions between methyl-

methodsTwenty consecutive patients with grade 3 or 4 glioma who had recurrence after postoperative radiotherapy (RT) between April 2016 and October 2017 were examined. The study was performed using simulation with the assumption that all patients received RT. The clinical target volume (CTV) was contoured using the Gd-enhanced region (CTV(Gd)), the tumor/normal tissue (T/N) ratios of

resultsThe Jaccard index (JI) for concordance of CTV (Gd) with CTVs using

conclusionsThe region of

Indexed as

Brain NeoplasmsGliomaHumansMagnetic Resonance ImagingMethioninePositron-Emission TomographyRacemethionineMethionineRacemethionine11C-methionineGliomaPositron emission tomographyRadiotherapy planning

Identifiers

PMID38356008
PMCPMC10954960
OpenAlexW4391809165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.